HercepTest™ mAb pharmDx

HercepTest™ mAb pharmDx

Companion diagnostics

Information

HercepTest™ mAb pharmDx for Dako Omnis is a semiquantitative immunohistochemical assay based on a primary monoclonal rabbit antibody (clone DG44) and an assay-specific visualization reagent. The assay determines HER2 protein overexpression in formalin-fixed, paraffin-embedded (FFPE) breast cancer tissues processed for histological evaluation. HercepTest™ mAb pharmDx for Dako Omnis is indicated as an aid in the assessment of breast cancer patients for whom Herceptin® (trastuzumab) treatment is being considered.
Agilent TechnologiesAgilent is a leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. Agilent’s expertise and trusted collaboration give them the highest confidence in our solutions. Due to the data privacy law, EBW and its organizer are not allowed to pass on your contact details to Agilent. To provide you with information on Agilent biobank sample quality control solutions, please complete register below on the document section. Thank You!

Log in